Cargando...
miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
BACKGROUND: Sorafenib can prolong the survival of patients with advanced hepatocellular carcinoma (HCC). However, drug resistance remains the main obstacle to improving its efficiency. This study aimed to explore the likely molecular mechanism of sorafenib resistance. METHODS: Differentially express...
Gardado en:
| Publicado en: | Ann Transl Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7859776/ https://ncbi.nlm.nih.gov/pubmed/33553331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-2081 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|